High-Throughput Screening of a 100,000-Compound Library for Inhibitors of Influenza A Virus (H3N2)
Open Access
- 1 October 2008
- journal article
- research article
- Published by Elsevier in SLAS Discovery
- Vol. 13 (9) , 879-887
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The 1918 Influenza Pandemic: Insights for the 21st CenturyThe Journal of Infectious Diseases, 2007
- A cell-based luminescence assay is effective for high-throughput screening of potential influenza antiviralsAntiviral Research, 2007
- The fight against new types of influenza virusBiotechnology Journal, 2006
- Antiviral agents active against influenza A virusesNature Reviews Drug Discovery, 2006
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- Are We Ready for Pandemic Influenza?Science, 2003
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997
- Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitroAntiviral Research, 1985